These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 6142756)

  • 21. Toxicity of p-methoxyphenol to dopamine neurons in the rat substantia nigra.
    Cumming P; Kamo H; McGeer EG; McGeer PL
    Neuropharmacology; 1987 Dec; 26(12):1795-7. PubMed ID: 2893988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of a unilateral stereotaxic injection of Tinuvin 123 into the substantia nigra on the nigrostriatal dopaminergic pathway in the rat.
    Jackson-Lewis V; Liberatore G
    Brain Res; 2000 Jun; 866(1-2):197-210. PubMed ID: 10825495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GM1 monosialoganglioside inner ester induces early recovery of striatal dopamine uptake in rats with unilateral nigrostriatal lesion.
    Raiteri M; Versace P; Marchi M
    Eur J Pharmacol; 1985 Dec; 118(3):347-50. PubMed ID: 4085560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
    Rosenblad C; Kirik D; Björklund A
    Exp Neurol; 2000 Feb; 161(2):503-16. PubMed ID: 10686072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 6-Hydroxydopamine-induced degeneration of nigral dopamine neurons: differential effect on nigral and striatal D-1 dopamine receptors.
    Porceddu ML; Giorgi O; De Montis G; Mele S; Cocco L; Ongini E; Biggio G
    Life Sci; 1987 Aug; 41(6):697-706. PubMed ID: 2956472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GM1 ganglioside treatment promotes recovery of striatal dopamine concentrations in the mouse model of MPTP-induced parkinsonism.
    Schneider JS; Yuwiler A
    Exp Neurol; 1989 Aug; 105(2):177-83. PubMed ID: 2568945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exogenous GM1 gangliosides induce partial recovery of the nigrostriatal dopaminergic system in MPTP-treated young mice but not in aging mice.
    Date I; Felten SY; Felten DL
    Neurosci Lett; 1989 Dec; 106(3):282-6. PubMed ID: 2601883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective enhancement of tubulin gene expression and increase in oligo(dT)-bound RNA in the rat brain after nigrostriatal pathway unilateral lesion and treatment with ganglioside.
    Yavin E; Gil S; Consolazione A; dal Toso R; Leon A
    J Neurosci Res; 1987; 18(4):615-20. PubMed ID: 3437475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density.
    Masuo Y; Pélaprat D; Montagne MN; Scherman D; Rostène W
    Brain Res; 1990 Mar; 510(2):203-10. PubMed ID: 1970504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopaminergic dendrites in the pars reticulata of the rat substantia nigra and their striatal input. Combined immunocytochemical localization of tyrosine hydroxylase and anterograde degeneration.
    Wassef M; Berod A; Sotelo C
    Neuroscience; 1981; 6(11):2125-39. PubMed ID: 6120482
    [No Abstract]   [Full Text] [Related]  

  • 31. Ultrastructure and immunocytochemistry of left and right nigrostriatal system after lesion of right side of substantia nigra of rat.
    Jedrzejewska A; Wierzba-Bobrowicz T; Olejniczak P; Poszwińska Z; Dymecki J
    Adv Neurol; 1990; 53():41-9. PubMed ID: 1978519
    [No Abstract]   [Full Text] [Related]  

  • 32. Lack of effect of cerebellectomy on ascending dopaminergic neurons in the rat brain.
    Lovell KL; Bruner CA; Moore KE
    Neurosci Lett; 1982 Oct; 32(2):187-92. PubMed ID: 7145238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diminished responses of nigral dopaminergic neurons to haloperidol and morphine following lesions in the striatum.
    Kondo Y; Iwatsubo K
    Brain Res; 1980 Jan; 181(1):237-40. PubMed ID: 7350960
    [No Abstract]   [Full Text] [Related]  

  • 34. The pesticide fipronil injected into the substantia nigra of male rats decreases striatal dopamine content: A neurochemical, immunohistochemical and behavioral study.
    Bharatiya R; Bratzu J; Lobina C; Corda G; Cocco C; De Deurwaerdere P; Argiolas A; Melis MR; Sanna F
    Behav Brain Res; 2020 Apr; 384():112562. PubMed ID: 32070689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistent MDMA-induced dopaminergic neurotoxicity in the striatum and substantia nigra of mice.
    Granado N; O'Shea E; Bove J; Vila M; Colado MI; Moratalla R
    J Neurochem; 2008 Nov; 107(4):1102-12. PubMed ID: 18823368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GM1 ganglioside treatment partially reverses the nigrostriatal dopamine defect in the weaver mutant mouse.
    Schneider JS; Smith MG; DiStefano L; Berrian J
    Brain Res; 1994 Feb; 636(2):353-6. PubMed ID: 7912161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic lithium administration alters behavioral recovery from nigrostriatal injury: effects on neostriatal [3H]spiroperidol binding sites.
    Kozlowski MR; Neve KA; Grisham JE; Marshall JF
    Brain Res; 1983 May; 267(2):301-11. PubMed ID: 6409351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotonergic sprouting is induced by dopamine-lesion in substantia nigra of adult rat brain.
    Zhou FC; Bledsoe S; Murphy J
    Brain Res; 1991 Aug; 556(1):108-16. PubMed ID: 1718555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions of exogenous L-dopa with nigrostriatal dopaminergic neurons in Parkinson's disease.
    Melamed E
    Adv Neurol; 1990; 53():61-6. PubMed ID: 2173376
    [No Abstract]   [Full Text] [Related]  

  • 40. Behavioural and morphological changes following treatment with GM-1 ganglioside of rats with an electrolytic lesion of the substantia nigra.
    Jackson EA; Jenner P; Marsden CD
    Neuropharmacology; 1989 Jun; 28(6):543-55. PubMed ID: 2569173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.